Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Santa Rosa
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Santa Rosa, CA

Studies commonly pay $75 to $4,500 per completed study

143 clinical trials are currently recruiting participants within 30 miles of Santa Rosa. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

143studies recruiting
8+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Santa Rosa right now

Top 25 of 143 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Persistent Corneal Epithelial Defect Phase 2 Interventional 84 participants sought
Glaukos Investigative Site — Petaluma, California (15.2 mi) · Sponsor: Glaukos Corporation

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Santa Rosa, California (0.6 mi) · Sponsor: AstraZeneca

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Providence Medical Foundation ( Site 9543) — Santa Rosa, California (0.6 mi) · Sponsor: Merck Sharp & Dohme LLC

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

Primary Open Angle Glaucoma Phase 3 Interventional 130 participants sought
North Bay Eye Associates /ID# 277071 — Petaluma, California (15.2 mi) · Sponsor: AbbVie

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: National Cancer Institute (NCI)

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Colorectal Neoplasms Phase 3 Interventional 1,000 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Janssen Research & Development, LLC

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Atherosclerosis Phase 2 Interventional 162 participants sought
NorthBay Clinical Research — Santa Rosa, California (0.6 mi) · Sponsor: Genentech, Inc.

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Urothelial Cancer Phase 2, Phase 3 Interventional 470 participants sought
Sutter Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Bristol-Myers Squibb

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
NorthBay Clinical Research, LLC — Santa Rosa, California (0.6 mi) · Sponsor: Boehringer Ingelheim

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Adjustment Disorder Phase 2 Interventional 100 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Reunion Neuroscience Inc

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Cardiotoxicity, HER2/Neu Positive Phase 3 Interventional 491 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Wake Forest University Health Sciences

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: National Cancer Institute (NCI)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia Phase 3 Interventional 303 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Lumbar Spinal Stenosis N/A Interventional 100 participants sought
Evolve Restorative Center — Santa Rosa, California (0.6 mi) · Sponsor: Pacific Research Institute

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,260 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Prostate Cancer, Metastatic Castration Resistant Prostate Cancer Phase 1 Interventional 174 participants sought
Providence Medical Group Oncology Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Astellas Pharma Global Development, Inc.

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Acne Phase 1, Phase 2 Interventional 800 participants sought
NorthBay Clinical Research- Site Number : 8400066 — Santa Rosa, California (0.6 mi) · Sponsor: Sanofi Pasteur, a Sanofi Company
Actively enrolling

Studies you may be able to join near Santa Rosa

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Santa Rosa

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Providence Medical Group Santa Rosa - Clinical Trials

3555 Round Barn Cir, Santa Rosa, CA 95403
(707) 521-3830

Siyan Clinical Corporation

★ 4.8 (564 reviews)
480 Tesconi Cir Ste B, Santa Rosa, CA 95401
(707) 206-7268

TrueNorth Health Center

★ 4.4
1551 Pacific Ave, Santa Rosa, CA 95404
(707) 586-5555

Santa Rosa Behavioral Healthcare Hospital

★ 2.2 (244 reviews)
1287 Fulton Rd, Santa Rosa, CA 95401
(707) 800-7700
"Everyone that works there (except for the kitchen staff) knows how to treat people and do their best even when others (patience) are not trying to he…"
— Lamar Manuel, 5★

Sunwise Clinical Research

★ 4.7
1371 Oakland Blvd #301, Walnut Creek, CA 94596
(925) 298-5147
"They are a great group of people"
— Tree Sap, 5★

Evolve Restorative Center

★ 4.1 (53 reviews)
220 Concourse Blvd, Santa Rosa, CA 95403
(844) 527-7369
"First time I've been to this practice....and it will be my last. Looks like a nice facility but staff are robotic and appear to care less about thei…"
— Mike Antill, 1★

Oakland Clinical

3300 Webster St #1106, Oakland, CA 94609
(510) 817-2000

CPMC Research Institute

★ 5.0
2330 Clay St, San Francisco, CA 94115
(415) 561-1785

Clinical trials in Santa Rosa: what's recruiting

The Santa Rosa area currently has 143 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Santa Rosa, the most active research areas are:

  • Cancer & Oncology14 studies
  • Heart & Vascular3 studies
  • Liver & Kidney2 studies
  • Lungs & Breathing1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Santa Rosa, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Santa Rosa

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Santa Rosa participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Santa Rosa pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Santa Rosa safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Santa Rosa, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Santa Rosa?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Santa Rosa typically complete one or two studies per year.

Paid clinical trials near Santa Rosa

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of CA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts